25021-263 : Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal


NDC: 25021-263
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Doxorubicin Hydrochloride Liposome
Dosage Form: Intravenous Injection, Suspension, Liposomal
Application #: ANDA219881
Rev. Date: 


NDC Package Codes:

  • 25021-263-10: 1 VIAL IN 1 CARTON (25021‑263‑10) / 10 ML IN 1 VIAL
  • 25021-263-25: 1 VIAL IN 1 CARTON (25021‑263‑25) / 25 ML IN 1 VIAL

Active Ingredients:

  • Doxorubicin Hydrochloride

Dosage Strength:

  • 2 mg/mL

Pharmaceutical Classes:

  • Anthracycline Topoisomerase Inhibitor [EPC]
  • Anthracyclines [CS]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0338-0080 Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
  • 0338-0086 Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
  • 59676-966 Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Janssen Products, Lp

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-263 QR Code

< Prev: 25021-262Next: 25021-300 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.